IL-17 Cytokines and Chronic Lung Diseases

Cells. 2022 Jul 6;11(14):2132. doi: 10.3390/cells11142132.

Abstract

IL-17 cytokines are expressed by numerous cells (e.g., gamma delta (γδ) T, innate lymphoid (ILC), Th17, epithelial cells). They contribute to the elimination of bacteria through the induction of cytokines and chemokines which mediate the recruitment of inflammatory cells to the site of infection. However, IL-17-driven inflammation also likely promotes the progression of chronic lung diseases, such as chronic obstructive pulmonary disease (COPD), lung cancer, cystic fibrosis, and asthma. In this review, we highlight the role of IL-17 cytokines in chronic lung diseases.

Keywords: IL-17; infection; inflammation; lung damage; lung diseases.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytokines / metabolism
  • Cytokines / pharmacology
  • Humans
  • Immunity, Innate
  • Interleukin-17* / metabolism
  • Interleukin-17* / pharmacology
  • Lung Diseases* / metabolism
  • Th17 Cells

Substances

  • Cytokines
  • Interleukin-17

Grants and funding

This study was supported by grants from Rolf M. Schwiete Stiftung to RB and the German Federal Ministry of Education and Research (BMBF), “Alternativmethoden zum Tierversuch” 3-REPLACE (16LW0140K) to CB.